{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:44:58Z","timestamp":1790196298589,"version":"4.1.0"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T00:00:00Z","timestamp":1683072000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Atypical antipsychotics (APs) modify the gut microbiome, and weight gain in response to AP could be mediated by the gut microbiome. Thus, the present study aimed to explore the changes in the gut bacterial microbiome in AP-exposed children with obesity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>To rule out the confounder of AP indication, the gut bacterial microbiome was compared between healthy controls (Con) and AP-exposed individuals with overweight (APO) or normal weight (APN). Fifty-seven AP-treated outpatients (21 APO and 36 APN) and 25 Con were included in this cross-sectional microbiota study.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>AP users, regardless of body mass index, exhibited decreased microbial richness and diversity and a distinct metagenomic composition compared to the Con. Although no differences in the microbiota structure were observed between APO and APN groups, the APO group was characterised by a higher abundance of <jats:italic>Megamonas<\/jats:italic> and <jats:italic>Lachnospira<\/jats:italic>. Additionally, the differences in the microbial functions were observed between APO and APN groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The gut bacterial microbiota of APO children revealed taxonomic and functional differences compared to Con and APN. Further studies are needed to verify these findings and to explore the temporal and causal relationships between these variables.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2023.1124846","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:26:09Z","timestamp":1683091569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":9,"title":["Gut microbiome profiles may be related to atypical antipsychotic associated overweight in Asian children with psychiatric disorder: a preliminary study"],"prefix":"10.3389","volume":"13","author":[{"given":"Shao-rui","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-yin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.135","article-title":"Use of the second-generation antipsychotic, risperidone, and secondary weight gain are associated with an altered gut microbiota in children","volume":"5","author":"Bahr","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"B2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1055\/a-1288-1061","article-title":"Review and consensus on pharmacogenomic testing in psychiatry","volume":"54","author":"Bousman","year":"2021","journal-title":"Pharmacopsychiatry"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202100857RR","article-title":"Metagenomic analysis reveals the signature of gut microbiota associated with human chronotypes","volume":"35","author":"Carasso","year":"2021","journal-title":"FASEB J."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.8317","article-title":"Alteration of the gut microbiota associated with childhood obesity by 16S rRNA gene sequencing","volume":"8","author":"Chen","year":"2020","journal-title":"PeerJ"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13394","article-title":"Fecal microbiota relationships with childhood obesity: a scoping comprehensive review","author":"de Cuevillas","year":"2022","journal-title":"Obes. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s40264-022-01252-6","article-title":"Laurent C weight gain during antipsychotic treatment in children, adolescents, and adults: a disproportionality analysis in the global pharmacovigilance database, vigibase","volume":"46","author":"Florentia","year":"2023","journal-title":"Drug Saf."},{"key":"B7","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1002\/phar.1890","article-title":"Interaction between atypical antipsychotics and the gut microbiome in a bipolar disease cohort","volume":"37","author":"Flowers","year":"2017","journal-title":"Pharmacotherapy"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.3390\/nu12041063","article-title":"Specific dietary components and gut microbiota composition are associated with obesity in children and adolescents with prader-willi syndrome","volume":"12","author":"Garcia-Ribera","year":"2020","journal-title":"Nutrients"},{"key":"B9","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1080\/15563650.2021.1946556","article-title":"Trends of prescription psychotropic medication exposures in pediatric patients, 2009-2018","volume":"60","author":"Hunter","year":"2022","journal-title":"Clin. Toxicol. (Phila)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1677","article-title":"Altered gut bacterial-fungal interkingdom networks in patients with current depressive episode","volume":"10","author":"Jiang","year":"2020","journal-title":"Brain Behav."},{"key":"B11","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jpsychires.2018.07.007","article-title":"Altered gut microbiota profile in patients with generalized anxiety disorder","volume":"104","author":"Jiang","year":"2018","journal-title":"J. Psychiatr. Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3945\/ajcn.117.156380","article-title":"Time of day and eating behaviors are associated with the composition and function of the human gastrointestinal microbiota","volume":"106","author":"Kaczmarek","year":"2017","journal-title":"Am. J. Clin. Nutr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1016\/j.jamda.2021.09.036","article-title":"Antipsychotic use and risk of stroke among community-dwelling people with alzheimer's disease","volume":"23","author":"Koponen","year":"2022","journal-title":"J. Am. Med. Dir Assoc."},{"key":"B14","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.pnpbp.2006.02.007","article-title":"New-onset type-2 diabetes associated with atypical antipsychotic medications","volume":"30","author":"Lambert","year":"2006","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1097\/01.jcp.0000203196.65710.2b","article-title":"Risperidone-related weight gain: genetic and nongenetic predictors","volume":"26","author":"Lane","year":"2006","journal-title":"J. Clin. Psychopharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s00787-013-0399-5","article-title":"Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review","volume":"22","author":"Mart\u00ednez-Ortega","year":"2013","journal-title":"Eur. Child Adolesc. Psychiatry"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0061217","article-title":"Phyloseq: an r package for reproducible interactive analysis and graphics of microbiome census data","volume":"8","author":"McMurdie","year":"2013","journal-title":"PLoS One"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e13321","DOI":"10.1111\/obr.13321","article-title":"Dose-response association of early-life antibiotic exposure and subsequent overweight or obesity in children: a meta-analysis of prospective studies","volume":"22","author":"Meng","year":"2021","journal-title":"Obes. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1038\/s41598-021-84928-w","article-title":"Gut microbiota markers associated with obesity and overweight in Italian adults","volume":"11","author":"Palmas","year":"2021","journal-title":"Sci. Rep."},{"key":"B20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1089\/cap.2006.0037","article-title":"Body mass indexes and lipid profiles in hospitalized children and adolescents exposed to atypical antipsychotics","volume":"17","author":"Patel","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1080\/15622975.2017.1347712","article-title":"CYP2C19*17 protects against metabolic complications of clozapine treatment","volume":"18","author":"Piatkov","year":"2017","journal-title":"World J. Biol. Psychiatry"},{"key":"B22","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.11128","article-title":"Liraglutide-induced structural modulation of the gut microbiota in patients with type 2 diabetes mellitus","volume":"9","author":"Shang","year":"2021","journal-title":"PeerJ"},{"key":"B24","first-page":"22","article-title":"The mini-international neuropsychiatric interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10","author":"Sheehan","year":"1998","journal-title":"J. Clin. Psychiatry"},{"key":"B25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1089\/cap.2021.0027","article-title":"Psychotropic drug prescription in children and adolescents: approved medications in European countries and the united states","volume":"32","author":"Smogur","year":"2022","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1099\/ijs.0.64318-0","article-title":"Alistipes onderdonkii sp. nov. and alistipes shahii sp. nov., of human origin","volume":"56","author":"Song","year":"2006","journal-title":"Int. J. Syst. Evol. Microbiol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.cmet.2015.07.007","article-title":"Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome","volume":"22","author":"Ussar","year":"2015","journal-title":"Cell Metab."},{"key":"B28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbr.2014.08.065","article-title":"Serotonin controlling feeding and satiety","volume":"277","author":"Voigt","year":"2015","journal-title":"Behav. Brain Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.schres.2018.05.017","article-title":"Changes in metabolism and microbiota after 24-week risperidone treatment in drug na\u00efve, normal weight patients with first episode schizophrenia","volume":"201","author":"Yuan","year":"2018","journal-title":"Schizophr. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"000639","DOI":"10.1099\/mgen.0.000639","article-title":"Association between metabolic status and gut microbiome in obese populations","volume":"7","author":"Zeng","year":"2021","journal-title":"Microb. Genom"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2147\/DMSO.S355749","article-title":"The impact of intestinal microorganisms and their metabolites on type 1 diabetes mellitus","volume":"15","author":"Zheng","year":"2022","journal-title":"Diabetes Metab. Syndr. Obes."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1124846\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T05:26:12Z","timestamp":1683091572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2023.1124846\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,3]]},"references-count":31,"alternative-id":["10.3389\/fcimb.2023.1124846"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2023.1124846","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,3]]},"article-number":"1124846"}}